Pharmacological inhibition of restenosis: Learning from experience

被引：18

作者：

Shaw, LA ^{[1
]}

Rudin, M ^{[1
]}

Cook, NS ^{[1
]}

机构：

[1] SANDOZ PHARMA AG,DEPT VASC DIS & OSTEOPOROSIS,PRECLIN RES,CH-4002 BASEL,SWITZERLAND

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1995年 / 16卷 / 12期

关键词：

D O I：

10.1016/S0165-6147(00)89085-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：401 / 404

页数：4

共 36 条

[1]

CHATTERJEE M, 1994, CIRCULATION, V90, P627

[2]

Cook N S, 1993, Blood Press, V2, P322, DOI 10.3109/08037059309077175

[3]

DEBLOIS D, 1992, CIRCULATION, V86, P226

[4]

DOUGLAS SA, 1995, CARDIOVASC RES, V29, P641, DOI 10.1016/0008-6363(96)88634-2

[5] A ROLE FOR ENDOGENOUS ENDOTHELIN-1 IN NEOINTIMAL FORMATION AFTER RAT CAROTID-ARTERY BALLOON ANGIOPLASTY - PROTECTIVE EFFECTS OF THE NOVEL NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670 [J].

DOUGLAS, SA ;

LOUDEN, C ;

VICKERYCLARK, LM ;

STORER, BL ;

HART, T ;

FEUERSTEIN, GZ ;

ELLIOTT, JD ;

OHLSTEIN, EH .

CIRCULATION RESEARCH, 1994, 75 (01) :190-197

[6] LONG-TERM EFFECTS OF ANGIOPEPTIN TREATMENT IN CORONARY ANGIOPLASTY - REDUCTION OF CLINICAL EVENTS BUT NOT ANGIOGRAPHIC RESTENOSIS [J].

EMANUELSSON, H ;

BEATT, KJ ;

BAGGER, JP ;

BALCON, R ;

HEIKKILA, J ;

PIESSENS, J ;

SCHAEFFER, M ;

SURYAPRANATA, H ;

FOEGH, M .

CIRCULATION, 1995, 91 (06) :1689-1696

[7] THE BASIS OF MOLECULAR STRATEGIES FOR TREATING CORONARY RESTENOSIS AFTER ANGIOPLASTY [J].

EPSTEIN, SE ;

SPEIR, E ;

UNGER, EF ;

GUZMAN, RJ ;

FINKEL, T .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (06) :1278-1288

[8]

FAHRY RD, 1993, CIRC RES, V72, P1202

[9]

FAHRY RD, 1992, BIOCHEM BIOPH RES CO, V182, P283

[10] PITUITARY FACTORS IN BLOOD-PLASMA ARE NECESSARY FOR SMOOTH-MUSCLE CELL-PROLIFERATION IN RESPONSE TO INJURY INVIVO [J].

FINGERLE, J ;

FAULMULLER, A ;

MULLER, G ;

BOWENPOPE, DF ;

CLOWES, MM ;

REIDY, MA ;

CLOWES, AW .

ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12) :1488-1495

← 1 2 3 4 →